← All stocks

BAX vs RGEN

Baxter International Inc. Common Stock vs Repligen Corporation Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

BAX
Baxter International Inc. Common Stock
Healthcare
22.93
11.79B
RGEN
Repligen Corporation Common Stock
Healthcare
180.71
9.98B
ACCE scores
BAX
RGEN
Composite score
Out of 100
54
52
Growth
64
40
Value
43
10
Quality
34
59
Momentum
76
97
Valuation
BAX
RGEN
Price
22.93
180.71
Market cap
11.79B
9.98B
Trailing P/E
0.00
242.32
Forward P/E
11.15
64.52
EV / EBITDA
25.33
57.47
Dividend yield
0.9%
0.0%
Profitability
BAX
RGEN
ROE
-14.4%
2.0%
Net margin
-9.3%
5.3%
Debt / equity
1.55
0.27
Free cash flow
323.00M
93.90M
Growth
BAX
RGEN
Revenue growth (YoY)
5.3%
11.9%
Earnings growth (YoY)
36.8%
-65.9%
Analyst target
28.73
189.48
See full analysis